254 Results for "

Cytosolic

" in MedChemExpress (MCE) Product Catalog:
Products (254)

254 Results for "Cytosolic" in MCE Product Catalog:

1715
1715 Publications Verification
Cat. No.: HY-100579
CAS No.: 347174-05-4
Purity:  99.71%
Synonyms: Fer-1
Target:  

Ferroptosis Fungal

Research Areas:  

Cancer

Ferrostatin-1 (Fer-1), a potent and selective ferroptosis inhibitor, suppresses Erastin-induced ferroptosis in HT-1080 cells (EC50=60 nM). Ferrostatin-1, a synthetic antioxidant, acts via a reductive mechanism to prevent damage to membrane lipids and thereby inhibits cell death. Ferrostatin-1 exhibits antifungal activity .
loading...
    loading...
27
27 Cited Publications
Cat. No.: HY-12512
CAS No.: 849214-04-6
Purity:  98.28%
Synonyms: Cyclic GMP-AMP; 3',3'-cGAMP
Target:  

STING

Research Areas:  

Inflammation/Immunology

cGAMP (Cyclic GMP-AMP) functions as an endogenous second messenger in metazoans and triggers interferon production in response to cytosolic DNA. cGAMP activates stimulator of interferon genes (STING), which activates a signaling cascade leading to the production of type I interferons and other immune mediators .
loading...
    loading...
27
27 Cited Publications
Cat. No.: HY-110385
CAS No.: 2407516-83-8
Purity:  98.47%
Synonyms: Cyclic GMP-AMP disodium; 3',3'-cGAMP disodium
cGAMP (Cyclic GMP-AMP) disodium functions as an endogenous second messenger in metazoans and triggers interferon production in response to cytosolic DNA. cGAMP diammonium activates stimulator of interferon genes (STING), which activates a signaling cascade leading to the production of type I interferons and other immune mediators .
loading...
    loading...
27
27 Cited Publications
Cat. No.: HY-110385A
Purity:  95.19%
Synonyms: Cyclic GMP-AMP diammonium; 3',3'-cGAMP diammonium
cGAMP (Cyclic GMP-AMP) diammonium functions as an endogenous second messenger in metazoans and triggers interferon production in response to cytosolic DNA. cGAMP diammonium activates stimulator of interferon genes (STING), which activates a signaling cascade leading to the production of type I interferons and other immune mediators .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-10801
CAS No.: 1233706-88-1
Purity:  ≥98.0%
Target:  

Phospholipase

Research Areas:  

Inflammation/Immunology

CAY10650 is a highly potent cytosolic phospholipase A2α (cPLA2α) inhibitor with an IC50 value of 12 nM. CAY10650 suppresses lipid droplets formation and PGE2 secretion .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-116044
CAS No.: 406191-34-2
Purity:  99.28%
BCATc Inhibitor 2 is a selective branched-chain aminotransferase (BCAT) inhibitor for research of neurodegenerative diseases. The IC50s of 0.2 μM, 0.8 μM and 3.0 μM for rat cytosolic isoenzyme rBCATc, human cytosolic isoenzyme hBCATc and rat mitochondrial isoenzyme rBCATm, respectively. BCATc, also called BCAT1, is in the cytoplasm .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-P1416
CAS No.: 881188-51-8
Target:  

Wnt

Research Areas:  

Cancer

Foxy-5, a WNT5A agonist, is a mimicking peptide of WNT5A which is a non-canonical member of the Wnt family. Foxy-5 triggers cytosolic free calcium signaling without affecting β-catenin activation and it impairs the migration and invasion of epithelial cancer cells. Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-P1416A
Target:  

Wnt

Research Areas:  

Cancer

Foxy-5 TFA, a WNT5A agonist, is a mimicking peptide of WNT5A which is a non-canonical member of the Wnt family. Foxy-5 TFA triggers cytosolic free calcium signaling without affecting β-catenin activation and it impairs the migration and invasion of epithelial cancer cells. Foxy-5 TFA effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-125006
CAS No.: 246020-68-8
Purity:  99.91%
Target:  

JNK p38 MAPK

Research Areas:  

Cancer

TRi-1 is a potent, specific and irreversible inhibitor of cytosolic thioredoxin reductase 1 (TXNRD1), with an IC50 of 12 nM. TRi-1 has little mitochondrial toxicity for anticancer therapy .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-119287
CAS No.: 109628-27-5
Purity:  99.50%
TSQ is a cytosolic zinc ion fluorescence probe that is membrane permeable and can be used for intracellular imaging of zinc proteins (λmax ~470 nm). TSQ can combine with Zn 2+ in the presence of Ca 2+ and Mg 2+ to produce blue fluorescence (Ex/Em = 334/495 nm) .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-108611
CAS No.: 149301-79-1
Purity:  ≥99.0%
Synonyms: Arachidonyl trifluoromethyl ketone
Target:  

Phospholipase

Research Areas:  

Cardiovascular Disease

AACOCF3 (Arachidonyl trifluoromethyl ketone) is a cell-permeant trifluoromethyl ketone analog of arachidonic acid. AACOCF3 is a potent and selective slow binding inhibitor of the 85-kDa cytosolic phospholipase A2 (cPLA2). AACOCF3 blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets. AACOCF3 inhibits glucose-induced insulin secretion from isolated rat islets. AACOCF3 has the potential for the research of cardiovascular disease .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-P0221
CAS No.: 137061-48-4
Synonyms: Pituitary Adenylate Cyclase Activating Polypeptide 38
PACAP (1-38), human, ovine, rat is a PAC1 receptor agonist. PACAP (1-38), human, ovine, rat binds to PACAP type I receptor, PACAP type II receptor VIP1, and PACAP type II receptor VIP2 with IC50s of 4 nM, 2 nM, and 1 nM, respectively. PACAP (1-38), human, ovine, rat increases the α-secretase activity. PACAP (1-38), human, ovine, rat elevates cytosolic Ca 2+, increases proliferation and increases phosphorylation of extracellular regulates kinase (ERK) and the epidermal growth factor receptor (EGFR). PACAP (1-38), human, ovine, rat demonstrates potent, efficacious, and sustained stimulatory effects on sympathetic neuronal NPY and catecholamine production. PACAP (1-38), human, ovine, rat can be used for neurotrophic and neuroprotective research .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-111376
CAS No.: 341973-06-6
Purity:  99.60%
Pyrrophenone is a potent and specific cytosolic phospholipase A2α (cPLA2α) inhibitor with an IC50 value of 4.2 nM .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-134640
CAS No.: 2267315-04-6
Purity:  98.22%
Target:  

AUTACs Mitophagy

Research Areas:  

Neurological Disease Cancer

AUTAC4 is a mitochondria-targeting autophagy-targeting chimera (AUTAC). AUTAC4 downregulates cytosolic proteins and promotes targeted mitochondrial turnover via mitophagy .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-112951
CAS No.: 2438721-44-7
Purity:  99.91%
Target:  

STING

Research Areas:  

Cancer

ChX710 could prime the type I interferon response to cytosolic DNA, which induces the ISRE promoter sequence, specific cellular Interferon-Stimulated Genes (ISGs), and the phosphorylation of Interferon Regulatory Factor (IRF) 3.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-P75897
Purity:  ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: Kelch-like ECH-associated protein 1; Cytosolic inhibitor of Nrf2; KEAP1; KEAP1
Species:  
Source:  
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-P72238
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Heat shock 86 kDa; Heat shock protein 90kDa alpha Cytosolic class A member 1; Heat shock protein 90kDa alpha Cytosolic class B member 1; Heat shock protein HSP 90 alpha ; Heat shock protein HSP 90 beta; Heat shock protein HSP 90-alpha; HS90A_HUMAN; HSP 84; HSP 86; Hsp 90; HSP86; HSP90A; HSP90AA1; HSP90AB1; HSP90B; HSPC1; HSPC2; HSPCAL1 ; HSPCAL4; Renal carcinoma antigen NY-REN-38
Species:  
Source:  
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-129225
CAS No.: 2138924-36-2
Purity:  99.71%
Research Areas:  

Cancer

WRR139 is a peptide vinyl sulfone involving in disease processes such as inflammation and cancer. WRR139 is also a cytosolic enzyme N-glycanase 1 (NGLY1) and Nrf1 inhibitor. WRR139 enhances Carfilzomib cytotoxicity against cancer cells .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B1060
CAS No.: 2375-03-3
Synonyms: Methylprednisolone hydrogen succinate sodium
Methylprednisolone succinate (Methylprednisolone hydrogen succinate) sodium is a prodrug of Methylprednisolone (HY-B0260) and glucocorticoid with immunosuppressant and anti-inflammatory activity. Methylprednisolone succinate sodium binds cytosolic glucocorticoid receptors, translocates to nuclei, and modulates target gene transcription. Methylprednisolone succinate sodium alters Bax, Bcl-2, occludin, and ZO-1 expression; attenuates TLR4/NF-κB signaling; suppresses proinflammatory cytokine production and immune cell activation. Methylprednisolone succinate sodium can be used for the research of intracranial haemorrhage, rheumatoid arthritis, multiple sclerosis, preterminal cancer, inflammatory conditions, shock, immediate-type hypersensitivity, acute myocardial ischemia, hypoxic heart muscle damage, and traumatic spinal cord injury .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B1900
CAS No.: 2921-57-5
Synonyms: Methylprednisolone hydrogen succinate
Methylprednisolone succinate (Methylprednisolone hydrogen succinate) is a prodrug of Methylprednisolone (HY-B0260) and glucocorticoid with immunosuppressant and anti-inflammatory activity. Methylprednisolone succinate binds cytosolic glucocorticoid receptors, translocates to nuclei, and modulates target gene transcription. Methylprednisolone succinate alters Bax, Bcl-2, occludin, and ZO-1 expression; attenuates TLR4/NF-κB signaling; suppresses proinflammatory cytokine production and immune cell activation. Methylprednisolone succinate can be used for the research of intracranial haemorrhage, rheumatoid arthritis, multiple sclerosis, preterminal cancer, inflammatory conditions, shock, immediate-type hypersensitivity, acute myocardial ischemia, hypoxic heart muscle damage, and traumatic spinal cord injury .
loading...
    loading...